Providing manufacturing solutions for MDI inhalers, nasal sprays, pharmaceutical and medical devices

The Company

Medicair is a rapidly growing company, manufacturing and distributing generic medicines in a broad range of categories. It produces and distributes branded generics and medical devices in the pharmaceutical forms of solids, semi-solids, liquids and sprays for nasal, inhalation and derma use, as well as food supplements and cosmetics. The company specializes in providing manufacturing solutions for MDI inhalers, nasal sprays, pharmaceutical and medical device sprays, being one of only a selected few companies in Europe to offer this type of production forms and have this in-depth know-how.


Our vision is to become a global leading provider of innovative and high quality medicinal solutions, with integrity, consistency, efficiency and a passion to bring new ideas and technologies to the market.


Starting its commercial operations in 1998, Medicair introduced 2 branded generic products to the Greek market with great success and built up on that by creating a rich and diverse portfolio of over 80 product licenses. In 2012, the company acquired its own manufacturing facilities, which allowed to focus on distribution to the global market. Medicair currently distributes its products to more than 20 countries around the globe, the same time several products are under registration in multiple countries. In order to ensure the finest quality, Medicair’s state of the art manufacturing facilities comply with the highest manufacturing process standards of “Good Manufacturing Practices”, as defined by the European Union and the World Health Organisation.


Our mission is to develop effective medicinal products and technologies that contribute to the improvement of the quality of life for a wide range of patients, in an affordable way that makes no compromises on quality.


Medicair is committed to growth and innovation, thus investing more than 7% of its turnover on research that allows the company to remain competitive and constantly improve, renew and upgrade its portfolio with advanced, effective and safe quality products. Today, the company is one of the major pharmaceutical companies in Greece, owning not only a respectable market share, but also valuable expertise. With more than 10 innovative products launching until 2020, the company is well on its way to the top.

Quality Assurance

Highest standards of quality and safety

To ensure the high quality of our products, we apply a number of processes and procedures and we have a set of clear and strict measures, controls and reviews. The industry’s current Good Manufacturing Practices (GMPs) are applied rigorously and Medicair abides by national and international legislation from the beginning of the manufacturing process until the very end.

Our state of the art manufacturing facilities, our highly-skilled team and our comprehensive policies and procedures all contribute to maintain the highest standards of quality and safety for our products.

Corporate Responsibility

We are creating impactful change for our employees, customers and the environment.

Medicair is keen on being a responsible corporate citizen. This is why we have a multifaceted corporate responsibility action plan in place. We are actively working on creating impactful change for our employees, our customers, our community and the environment.

Our approach includes:

– Compliance with all local and international standards regarding environmental performance.

– Strong focus on our Health and Safety company culture.

– Providing effective solutions to our customers whilst applying innovative methods to minimize our impact on the environment.

– Extensive use of recycled materials where possible.

– Continuous monitoring of our operations to find more ways to improve our environmental performance.

– Engaging with organisations that work on initiatives making a positive impact on local, national and global levels.